General Information of the Compound
| Compound ID |
CP0393185
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-[4-[4-[(3,5-dihydroxyphenyl)methyl]piperazin-1-yl]phenyl]-1-(1-methyl-4,10-dihydropyrazolo[4,3-c][1,5]benzodiazepin-5-yl)ethanone
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C30H32N6O3
|
||||||||||||||||||
| Molecular Weight |
524.625
|
||||||||||||||||||
| Canonical SMILES |
Cn1ncc2CN(C(=O)Cc3ccc(cc3)N3CCN(Cc4cc(O)cc(O)c4)CC3)c3ccccc3Nc12
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C30H32N6O3/c1-33-30-23(18-31-33)20-36(28-5-3-2-4-27(28)32-30)29(39)16-21-6-8-24(9-7-21)35-12-10-34(11-13-35)19-22-14-25(37)17-26(38)15-22/h2-9,14-15,17-18,32,37-38H,10-13,16,19-20H2,1H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
WLJQKSQMKGCUEE-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01658, Oxytocin receptor
Protein ID: PT01839, Vasopressin V1a receptor